Singular Genomics Systems Inc

-0.16 (-5.42%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)199.20M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.65 Million
Adjusted EPS-$0.43
See more estimates
10-Day MA$2.76
50-Day MA$2.25
200-Day MA$2.95
See more pivots

Singular Genomics Systems Inc Stock, NASDAQ:OMIC

3010 Science Park Road, Suite 100, San Diego, California 92121
United States of America
Phone: +1.858.333.7830
Number of Employees: 221


Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.